Agilent Technologies "announced that its board of directors has approved a new share repurchase program. The 2023 program authorizes the purchase of up to $2 billion of the company’s common stock. The new program will begin March 1."
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on A:
- Agilent invests $725M for manufacturing of therapeutic nucleic acids
- Gordon Haskett wonders if Guardant could be ‘shoehorned’ into Agilent search
- Agilent, Akoya to develop diagnostic solutions for tissue analysis
- Agilent VP Ancher-Jensen sells $4.6M of shares
- Agilent Resolution ctDx FIRST gets FDA approval as NSCLC test
